Guggenheim Capital’s Phibro Animal Health PAHC Stock Holding History

Guggenheim Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Buy	+17,288	New	+$729K	﹤0.01%	1261
2026 Q1	–	Sell	-30,693	Closed	-$1.15M	–	1744
2025 Q4	$1.15M	Buy	+30,693	New	+$1.25M	0.01%	878
2018 Q4	–	Sell	-8,865	Closed	-$380K	–	2317
2018 Q3	$380K	Buy	8,865 +2,078	+31%	+$98.2K	﹤0.01%	2109
2018 Q2	$313K	Sell	6,787 -25,945	-79%	-$1.15M	﹤0.01%	2170
2018 Q1	$1.3M	Buy	32,732 +76	+0.2%	+$2.81K	﹤0.01%	1925
2017 Q4	$1.1M	Buy	+32,656	New	+$1.16M	﹤0.01%	2028
2016 Q4	–	Sell	-18,848	Closed	-$512K	–	2953
2016 Q3	$512K	Sell	18,848 -3,109	-14%	-$70.3K	﹤0.01%	2379
2016 Q2	$410K	Buy	21,957 +150	+0.7%	+$3.13K	﹤0.01%	2432
2016 Q1	$590K	Sell	21,807 -3,628	-14%	-$104K	﹤0.01%	2305
2015 Q4	$766K	Buy	+25,435	New	+$816K	﹤0.01%	2234

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Guggenheim Capital's PAHC Position: Q2 2026 in Review

Guggenheim Capital opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 17,288 shares worth $543K. The stake represents ﹤0.01% of the portfolio and ranks #1261 among its holdings. This is a return to the name: Guggenheim Capital previously reported a position in PAHC as recently as Q4 2025.

Guggenheim Capital first reported a position in PAHC in Q4 2015 and has held it in 10 quarters since. The position peaked at $1.3M in Q1 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Guggenheim Capital held 17,288 shares of Phibro Animal Health worth $543K as of Q2 2026.
Phibro Animal Health was a new Guggenheim Capital position in Q2 2026.
Phibro Animal Health made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1261 holding.
Guggenheim Capital first reported a position in Phibro Animal Health in Q4 2015 and has held it in 10 quarters since.
Guggenheim Capital's Phibro Animal Health position peaked at $1.3M in Q1 2018.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.